Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder characterized by developmental and physical abnormalities. It affects an estimated 1 in 10,000 to 30,000 live births, making it a relatively uncommon condition. CdLS is caused by mutations in specific genes, which play a crucial role in early development. The syndrome is associated with distinctive facial features, growth delays, intellectual disabilities, and various organ system abnormalities. Although CdLS can vary in severity, early diagnosis and intervention can greatly improve the quality of life for individuals affected by this syndrome.
Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder that affects multiple organ systems and causes developmental delays. The prevalence of CdLS is estimated to be around 1 in 10,000 to 30,000 live births, making it a relatively rare condition.
Although CdLS can affect individuals of any gender or ethnic background, it appears to be slightly more common in males than females. The syndrome is typically diagnosed in infancy or early childhood based on the presence of characteristic physical features and developmental delays.
While the exact cause of CdLS is not fully understood, it is believed to be primarily caused by mutations in certain genes that play a role in early development. These genetic mutations can occur spontaneously or be inherited from an affected parent.
Individuals with CdLS may experience a wide range of symptoms, including distinctive facial features, growth delays, intellectual disabilities, limb abnormalities, and gastrointestinal issues. The severity of symptoms can vary significantly between individuals, even among affected family members.
Due to its rarity, CdLS often requires specialized medical care and support services. Early intervention and ongoing management can help individuals with CdLS reach their full potential and improve their quality of life.